Valuation: Strides Pharma Science Limited

Market Cap 98.51B 1.04B 929M 855M 774M 1.45B 1.47B 10.19B 4.09B 51.82B 3.89B 3.81B 163B P/E 2027 *
15.7x
P/E 2028 * 11.2x
Enterprise Value 98.51B 1.04B 929M 855M 774M 1.45B 1.47B 10.19B 4.09B 51.82B 3.89B 3.81B 163B EV / Sales 2027 *
1.69x
EV / Sales 2028 * 1.43x
Free-Float
68.11%
Yield 2027 *
0.28%
Yield 2028 * 0.28%
1 day-2.62%
1 week+5.32%
Current month-4.57%
1 month-4.57%
3 months-0.37%
6 months+3.09%
Current year+18.71%
1 week 972
Extreme 972
1,116.4
1 month 972
Extreme 972
1,116.4
Current year 768.65
Extreme 768.65
1,260.9
1 year 768.65
Extreme 768.65
1,260.9
3 years 467
Extreme 467
1,675
5 years 263.35
Extreme 263.35
1,675
10 years 263.35
Extreme 263.35
1,675
Manager TitleAgeSince
Chief Executive Officer - 01/06/2024
Director of Finance/CFO 42 01/06/2024
Chief Tech/Sci/R&D Officer - 21/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 18/05/2017
Director/Board Member 82 18/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.62%+5.32%+25.39%+118.64% 1.04B
+3.19%+11.31%+67.86%+150.58% 1,263B
-0.73%+3.56%+44.51%+85.81% 658B
+1.41%+3.24%+29.22%+107.83% 521B
+0.42%+3.20%+54.15%+67.18% 391B
+2.18%+2.93%+73.30%+45.62% 369B
+1.12%+4.52%+35.30%+58.08% 307B
+6.96%+8.86%+11.27%+36.62% 290B
+1.15%+6.09%+59.59%+77.06% 252B
+3.06%+9.38%+44.11%+119.47% 212B
Average +1.29%+5.84%+44.47%+86.69% 426.3B
Weighted average by Cap. +1.19%+6.60%+50.87%+98.32%

Financials

2027 *2028 *
Net sales 58.23B 613M 549M 505M 458M 856M 872M 6.02B 2.42B 30.63B 2.3B 2.25B 96.6B 69.12B 728M 652M 600M 543M 1.02B 1.03B 7.15B 2.87B 36.36B 2.73B 2.67B 115B
Net income 6.28B 66.11M 59.21M 54.46M 49.35M 92.24M 93.97M 649M 261M 3.3B 248M 243M 10.41B 8.8B 92.66M 82.99M 76.33M 69.16M 129M 132M 910M 365M 4.63B 348M 340M 14.6B
Net Debt - -
Projected Income Statement - Annual - Strides Pharma Science Limited
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
30/10/26 ₹1,068.80 -2.62% 2,677,985
29/10/26 ₹1,097.50 +1.10% 203,597
28/10/26 ₹1,085.60 -0.70% 396,045
27/10/26 ₹1,093.30 +5.83% 787,306
26/10/26 ₹1,033.10 +1.80% 281,520
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Strides Pharma Science Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,068.80INR
Average target price
1,338.67INR
Spread / Average Target
+25.25%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Strides Pharma Science Limited
  1. Stock Market
  2. Stocks
  3. STAR Stock